...is changing its organizational structure to focus on finding a path forward for the therapy. Gene Biotherapeutics Inc....

...pharma industry another approach to tackle heart disease. A growing number of companies - including Taxus Cardium...

...Ear; Heart; Liver Phase III Ascend Biopharmaceuticals Ltd.; GenVec Inc. (NASDAQ:GNVC); Novartis AG (NYSE:NVS; SIX:NOVN); Taxus Cardium...
...MultiVir Inc. , Novartis, PNP Therapeutics Inc. , Shenzhen SiBiono GeneTech Co. Ltd. , Taxus Cardium...

...Taxus Cardium granted Shenzhen the first right to negotiate for an exclusive license to develop and...
...Shenzhen will purchase 15% of Taxus’ Angionetics Inc. subsidiary for $3 million by May 30. Taxus Cardium...

...CAD). Dr. Reddy’s declined to disclose additional details, and Taxus did not respond to inquiries. Taxus Cardium...

...play La Jolla Pharmaceutical Co. (NASDAQ:LJPC) hired Dennis Mulroy as CFO. He was CFO at Taxus Cardium...

...patients treated with Generx experienced an improvement in RPDS. The trial is enrolling 100 patients. Taxus Cardium...

...Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM), San Diego, Calif. Business: Cardiovascular Appointed: John Wallace, president of...

...vedolizumab Moderate to severe Crohn's disease PDUFA date 6/18/14 Taxus Cardium Pharmaceuticals Group Inc. (OTCQB:CRXM) (formerly Cardium...

...Cardium Therapeutics Inc. changed its name to Taxus Cardium and partnered with Shanxi Taxus to promote each...
...apply "commercially reasonable efforts" to assist Taxus Cardium to develop and refine a plan to commercialize Taxus Cardium's...
...Taxus Cardium received an initial tranche of $500,000 through the sale of 714,286 shares at $0.70. Taxus Cardium...